116 related articles for article (PubMed ID: 18154909)
1. Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors.
Krull KR; Brouwers P; Jain N; Zhang L; Bomgaars L; Dreyer Z; Mahoney D; Bottomley S; Okcu MF
J Pediatr; 2008 Jan; 152(1):101-5. PubMed ID: 18154909
[TBL] [Abstract][Full Text] [Related]
2. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia.
Eissa DS; Ahmed TM
Blood Coagul Fibrinolysis; 2013 Mar; 24(2):181-8. PubMed ID: 23183238
[TBL] [Abstract][Full Text] [Related]
3. Genotyping of two single nucleotide polymorphisms in 5,10-methylenetetrahydrofolate reductase by multiplex polymerase chain reaction and capillary electrophoresis.
Cheng HL; Chiou SS; Liao YM; Chen YL; Wu SM
J Chromatogr A; 2011 Apr; 1218(15):2114-20. PubMed ID: 20870238
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia.
Pakakasama S; Kanchanakamhaeng K; Kajanachumpol S; Udomsubpayakul U; Sirachainan N; Thithapandha A; Hongeng S
Ann Hematol; 2007 Aug; 86(8):609-11. PubMed ID: 17323057
[No Abstract] [Full Text] [Related]
5. 5,10-methylenetetrahydrofolate reductase (MTHFR) polymorphisms and the risk of acute lymphoblastic leukemia (ALL) in Filipino children.
Alcasabas P; Ravindranath Y; Goyette G; Haller A; Del Rosario L; Lesaca-Medina MY; Darga L; Ostrea EM; Taub JW; Everson RB
Pediatr Blood Cancer; 2008 Aug; 51(2):178-82. PubMed ID: 18421714
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.
Patiño-García A; Zalacaín M; Marrodán L; San-Julián M; Sierrasesúmaga L
J Pediatr; 2009 May; 154(5):688-93. PubMed ID: 19159907
[TBL] [Abstract][Full Text] [Related]
7. DHFR 19-bp insertion/deletion polymorphism and MTHFR C677T in adult acute lymphoblastic leukaemia: is the risk reduction due to intracellular folate unbalancing?
Gemmati D; De Mattei M; Catozzi L; Della Porta M; Serino ML; Ambrosio C; Cuneo A; Friso S; Krampera M; Orioli E; Zeri G; Ongaro A
Am J Hematol; 2009 Aug; 84(8):526-9. PubMed ID: 19536847
[No Abstract] [Full Text] [Related]
8. Folate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapy.
Kamdar KY; Krull KR; El-Zein RA; Brouwers P; Potter BS; Harris LL; Holm S; Dreyer Z; Scaglia F; Etzel CJ; Bondy M; Okcu MF
Pediatr Blood Cancer; 2011 Sep; 57(3):454-60. PubMed ID: 21618410
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis.
Vagace JM; Caceres-Marzal C; Jimenez M; Casado MS; de Murillo SG; Gervasini G
Am J Hematol; 2011 Jan; 86(1):98-101. PubMed ID: 21064136
[TBL] [Abstract][Full Text] [Related]
10. Folate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemia.
Yousef AM; Farhad R; Alshamaseen D; Alsheikh A; Zawiah M; Kadi T
Cancer Chemother Pharmacol; 2019 Apr; 83(4):755-762. PubMed ID: 30684021
[TBL] [Abstract][Full Text] [Related]
11. A psycho-genetic study of associations between the symptoms of binge eating disorder and those of attention deficit (hyperactivity) disorder.
Davis C; Patte K; Levitan RD; Carter J; Kaplan AS; Zai C; Reid C; Curtis C; Kennedy JL
J Psychiatr Res; 2009 Apr; 43(7):687-96. PubMed ID: 19041097
[TBL] [Abstract][Full Text] [Related]
12. Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate.
van Kooten Niekerk PB; Schmiegelow K; Schroeder H
Eur J Haematol; 2008 Nov; 81(5):391-8. PubMed ID: 18691257
[TBL] [Abstract][Full Text] [Related]
13. Subacute leukencephalopathy after low-dose intrathecal methotrexate in an adolescent heterozygous for the MTHFR C677T polymorphism.
Strunk T; Gottschalk S; Goepel W; Bucsky P; Schultz C
Med Pediatr Oncol; 2003 Jan; 40(1):48-50. PubMed ID: 12426687
[No Abstract] [Full Text] [Related]
14. 5,10-Methylenetetrahydrofolate reductase (MTHFR) low activity genotypes reduce the risk of relapse-related acute lymphoblastic leukemia (ALL).
Karas Kuzelicki N; Milek M; Jazbec J; Mlinaric-Rascan I
Leuk Res; 2009 Oct; 33(10):1344-8. PubMed ID: 19178944
[TBL] [Abstract][Full Text] [Related]
15. MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patients.
Chiusolo P; Reddiconto G; Farina G; Mannocci A; Fiorini A; Palladino M; La Torre G; Fianchi L; Sorà F; Laurenti L; Leone G; Sica S
Leuk Res; 2007 Dec; 31(12):1669-74. PubMed ID: 17512587
[TBL] [Abstract][Full Text] [Related]
16. Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder.
Ribasés M; Hervás A; Ramos-Quiroga JA; Bosch R; Bielsa A; Gastaminza X; Fernández-Anguiano M; Nogueira M; Gómez-Barros N; Valero S; Gratacòs M; Estivill X; Casas M; Cormand B; Bayés M
Biol Psychiatry; 2008 May; 63(10):935-45. PubMed ID: 18179783
[TBL] [Abstract][Full Text] [Related]
17. C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation.
De Mattia E; Toffoli G
Eur J Cancer; 2009 May; 45(8):1333-51. PubMed ID: 19144510
[TBL] [Abstract][Full Text] [Related]
18. [Combination of DRD4 and DAT1 genotypes is an important risk factor for attention deficit disorder with hyperactivity families living in Santiago, Chile].
Henríquez B H; Henríquez H M; Carrasco Ch X; Rothhammer A P; Llop R E; Aboitiz F; Rothhammer E F
Rev Med Chil; 2008 Jun; 136(6):719-24. PubMed ID: 18769827
[TBL] [Abstract][Full Text] [Related]
19. [Attention deficit/hyperactivity disorder: burden of the disease according to subtypes in recently diagnosed children].
Escobar R; Hervas A; Soutullo C; Mardomingo MJ; Uruñuela A; Gilaberte I
Actas Esp Psiquiatr; 2008; 36(5):285-94. PubMed ID: 18830848
[TBL] [Abstract][Full Text] [Related]
20. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
Biederman J; Pliszka SR
J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
